GB2064 (lenumlostat) shows preliminary evidence of bone marrow collagen fibrosis reduction with manageable tolerability in JAK inhibitor-refractory myelofibrosis: results from the MYLOX-1 phase IIa study

Haematologica 2026 Open access

Read full text
Authors: Richard F. Schlenk, Claire N. Harrison, Francesca Palandri, Marco De Gobbi, Federico Itri, Raajit Rampal, Dipti Talaulikar, Brian Jacoby, Vassilios Aslanis, Robert J. Slack, James A. Roper, Hans Thalsgård Schambye
+2 more Bhupinder Singh, John Mascarenhas
DOI: 10.3324/haematol.2025.289108
Cited by: 1

Fields of Study & Subjects

Myeloproliferative Neoplasms: Diagnosis and Treatment Multiple Myeloma Research and Treatments Chronic Myeloid Leukemia Treatments

Publication details

Journal / source
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Volume
111
Issue
8
Pages
2797–2800
Publication date
5 March 2026
Language
EN